Allogeneic peripheral blood stem cell transplantation with CD34+-cell selection and delayed T-cell add-back in adults. Results of a single center pilot study

Haematologica

Volumn 85, Issue 11, 2000, Pages 1165-1171

  Martino, R ^a   Martin Henao, G ^a   Sureda, A ^a   Altes, A ^a   Canals, C ^a   Brunet, S ^a   Sierra, J ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Allogeneic; Graft versus host disease; Hematopoietic stem cell transplantation; T cell depletion

Indexed keywords

CD34 ANTIGEN; CYCLOSPORIN A;

ADULT; ARTICLE; CHIMERA; CLINICAL ARTICLE; FEMALE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; MALE; MORTALITY; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TREATMENT OUTCOME;

ANTIGENS, CD34; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; PILOT PROJECTS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0033659403     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. T-cell depletion of HLA-identical transplants in leukemia
2. Outcome after allogeneic bone marrow transplant for leukemia in older adults
3. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease
4. Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity, without severe graft-versus-host disease
5. T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and posttransplant administration of donor's peripheral blood lymphocytes for prevention of relapse
6. T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect
7. Allogeneic cell transplantation with rhG-CSF mobilized CD34+ selected PBPC in conjunction with adoptive immunotherapy for adults with hematologic malignancy
8. The influence of intensifying the conditioning regimen and the impact of pre-emptive donor leukocyte infusions after T-cell depleted BMT
9. CD8-depleted donor lymphocyte infusions as adoptive immunotherapy after CD34-selected peripheral blood stem cell transplantation
10. Early incremental T-cell add-back after allogeneic transplantation of Clinimacs separated peripheral blood stem cells
11. CD8+ T cell depleted allogeneic bone marrow transplantation followed by CD4+ donor lymphocyte infusion for patients with multiple myeloma
12. Prophylactic reinfusion of T cells for T cell-depleted allogeneic bone marrow transplantation
13. Allogeneic transplantation of selected CD34+ cells from peripheral blood: Experience of 62 cases using immunoadsorption or immunomagnetic technique
14. Isolation of CD34+ progenitor cells from peripheral blood by use of an automated immunomagnetic selection system: Factors affecting the results
15. 1994 Consensus Conference on Acute GVHD Grading
16. IBMTR Severity Index for grading acute graft-versus-host disease: Retrospective comparison with Glucksberg grade
17. Comparison of the classic Glucksberg criteria and the IBMTR Severity Index for grading acute graft-versus-host disease following HLA-identical sibling stem cell transplantation. International Bone Marrow Transplant Registry
18. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients
19. Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: A single-center experience
20. Various patterns of chimerism after allogeneic bone marrow transplantation for advanced chronic lymphocytic leukemia
21. T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation
22. Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: Impact of donor lymphocyte infusion
23. Cell therapy: Achievements and perspectives